von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma A
One trial evaluated TB4 for heart health, finding that the peptide could protect and repair the heart in patients with acute myocardial infarction, and a separate trial found that TB4 improved outcomes during congenital heart surgery.21 The review also mentions a few clinical trials related to eye health, with results showing that TB4 can reduce eye dryness, relieve ocular discomfort, lower inflammation in the conjunctiva, and more
The research is unambiguous
The benefit-risk profile at both the 9 mg and 12 mg doses appears favorable, though individual tolerability will vary as it does with all incretin-based therapies
Together, they create an environment where natural GLP-1 production is maximally supported through multiple independent pathways